BioMimetix Pharmaceutical Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Grant
- Financing Rounds
-
5
BioMimetix Pharmaceutical General Information
Description
Developer of biopharmaceutical products intended for the treatment of cancer in Greenwood Village, Colorado. The company is developing a new class of compounds from previous metalloporphyrin antioxidant mimetics for the treatment of various diseases including radiation toxicity, a frequent side effect of cancer treatment using radiation therapy, providing pharmaceutical products to clients for the treatment of inflammatory and neoplastic diseases.
Contact Information
Website
www.biomimetixpharma.comCorporate Office
- 5340 South Quebec Street
- Suite 345N
- Greenwood Village, CO 80111
- United States
Corporate Office
- 5340 South Quebec Street
- Suite 345N
- Greenwood Village, CO 80111
- United States
BioMimetix Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioMimetix Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioMimetix Pharmaceutical Patents
BioMimetix Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240342190-A1 | Methods for reducing ischemia-reperfusion injuries | Pending | 13-Apr-2023 | ||
| US-20230391809-A1 | Hydrophobic compositions including a hydrophilic active ingredient and methods relating thereto | Pending | 07-Jun-2022 | ||
| US-20220193090-A1 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | Active | 04-Apr-2017 | ||
| US-20210106594-A1 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | Active | 04-Apr-2017 | ||
| US-11285162-B2 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | Active | 04-Apr-2017 | A61P35/00 |
BioMimetix Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioMimetix Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioMimetix Pharmaceutical FAQs
-
When was BioMimetix Pharmaceutical founded?
BioMimetix Pharmaceutical was founded in 2011.
-
Where is BioMimetix Pharmaceutical headquartered?
BioMimetix Pharmaceutical is headquartered in Greenwood Village, CO.
-
What is the size of BioMimetix Pharmaceutical?
BioMimetix Pharmaceutical has 11 total employees.
-
What industry is BioMimetix Pharmaceutical in?
BioMimetix Pharmaceutical’s primary industry is Biotechnology.
-
Is BioMimetix Pharmaceutical a private or public company?
BioMimetix Pharmaceutical is a Private company.
-
What is BioMimetix Pharmaceutical’s current revenue?
The current revenue for BioMimetix Pharmaceutical is .
-
How much funding has BioMimetix Pharmaceutical raised over time?
BioMimetix Pharmaceutical has raised $8.1M.
-
Who are BioMimetix Pharmaceutical’s investors?
Omni Bio Pharmaceutical has invested in BioMimetix Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
